Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematopoietic stem cell gene therapy.

David W Emery1, Tamon Nishino, Ken Murata

  • 1University of Washington Department of Medicine, Seattle 98195-7720, USA.

International Journal of Hematology
|May 10, 2002
PubMed
Summary

Hematopoietic stem cell (HSC) gene therapy shows promise for blood disorders but faces challenges. Recent advances aim to improve gene transfer, cell engraftment, and expression for better clinical outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sexually dimorphic processing of pheromonal information in mice.

Current opinion in neurobiology·2025
Same author

Large-scale discovery of potent, compact and erythroid specific enhancers for gene therapy vectors.

Nature communications·2025
Same author

Editorial: DNA replication barriers and the origins of cancer.

Frontiers in cell and developmental biology·2025
Same author

The DNA Damage Response as an Auxiliary Indicator of Senescence in Cancer: A User-Friendly Toolkit of Markers and Detection Methods.

Methods in molecular biology (Clifton, N.J.)·2025
Same author

Impaired pheromone detection and abnormal sexual behavior in female mice deficient for ancV1R.

Current biology : CB·2024
Same author

Neural basis for pheromone signal transduction in mice.

Frontiers in neural circuits·2024

Area of Science:

  • Hematology
  • Gene Therapy
  • Stem Cell Biology

Background:

  • Hematopoietic stem cells (HSCs) are crucial for treating hematologic diseases.
  • Gene therapy targeting HSCs offers significant therapeutic potential.
  • Current limitations hinder widespread clinical success.

Purpose of the Study:

  • To outline the fundamental approach of HSC gene therapy.
  • To review key historical clinical trials in the field.
  • To highlight recent advancements addressing current limitations.

Main Methods:

  • Review of established HSC gene therapy protocols.
  • Analysis of seminal and recent clinical trial data.
  • Description of novel techniques to enhance gene transfer and expression.

Related Experiment Videos

Main Results:

  • Gene therapy for hematologic diseases is a developing field.
  • Challenges include inefficient gene transfer, engraftment, and expression.
  • Recent innovations show promise in overcoming these hurdles.

Conclusions:

  • HSC gene therapy holds great promise for hematologic diseases.
  • Overcoming technical limitations is key to clinical translation.
  • Ongoing research is paving the way for improved therapeutic strategies.